Target of the Week - GLS Antibodies

|
Dear Cancer Researcher, Abgent offers a portfolio of antibodies for the detection of Glutaminase in western blotting, immunohistochemistry , immunofluorescence, and flow cytometry. Cat# AP8809b ( click to see all 13 images) is validated in kidney and brain tissues for human, mouse, and rat. Glutaminase is the major enzyme yielding glutamate from glutamine. This enzyme catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Significance also arises from implication in behavior disturbances in which glutamate acts as a neurotransmitter. To find the right antibody for your research, please visit Abgent Glutamine Antibodies. More Data for GLS (C-term) Antibody (Cat# AP8809b) |
GLS (C-term) Antibody Cat# AP8809b to human brain, mouse brain and rat kidney tissue lysates. |
![]() |
![]() |
![]() |






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.


